7
Views
0
CrossRef citations to date
0
Altmetric
Review

Maternal epilepsy and adverse pregnancy outcomes

&
Pages 347-355 | Published online: 10 Jan 2014

References

  • Morell MJ. Seizures and epilepsy in women. In: Neurological Disease in Women. Kaplan P (Ed.). Demos Medical Publishing, NY, USA, 219 (2006).
  • Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin. Proc.71(6), 576–586 (1996).
  • Fairgrieve SD, Jackson M, Jonas P et al. Population based, prospective study of the care of women with epilepsy in pregnancy. Br. Med. J.321(7262), 674–675 (2000).
  • Hiilesmaa VK, Bardy A, Teramo K. Obstetric outcome in women with epilepsy. Am. J. Obstet. Gynecol.152(5), 499–504 (1985).
  • Richmond JR, Krishnamoorthy P, Andermann E, Benjamin A. Epilepsy and pregnancy: an obstetric perspective. Am. J. Obstet. Gynecol.190(2), 371–379 (2004).
  • Kaneko S. Epilepsy, pregnancy, and the child. Epilepsia41(Suppl. 9), 8–13 (2000).
  • Tomson T, Battino D. Pregnancy and epilepsy: what should we tell our patients? J. Neurol.256(6), 856–862 (2009).
  • Nelson-Piercy C. Neurological problems. In: Handbook of Obstetric Medicine (2nd Edition). Nelson-Piercy C (Ed.). Martin Dunitz Ltd, London, UK, 156–164 (2002).
  • Borthen I, Eide MG, Veiby G, Daltveit AK, Gilhus NE. Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG116(13), 1736–1742 (2009).
  • Veiby G, Daltveit AK, Engelsen BA, Gilhus NE. Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia50(9), 2130–2139 (2009).
  • CEMACH: introduction. In: Why Mothers Die 2000–2002: The Sixth Report. Lewis G (Ed.). Royal College of Obstetricians and Gynecologists, London, UK (2004).
  • Sabers A. Influences on seizure activity in pregnant women with epilepsy. Epilepsy Behav.15(2), 230–234 (2009).
  • Vajda FJ, Hitchcock A, Graham J, O’Brien T, Lander C, Eadie M. Seizure control in antiepileptic drug-treated pregnancy. Epilepsia49(1), 172–176 (2008).
  • EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology66(3), 354–360 (2006).
  • EURAP Study Group. Utilization of antiepileptic drugs during pregnancy: comparative patterns in 38 countries based on data from the EURAP registry. Epilepsia50(10), 2305–2309 (2009).
  • Meadow SR. Anticonvulsant drugs and congenital abnormalities. Lancet2(7581), 1296 (1968).
  • Meador KJ, Penovich P, Baker GA et al. Antiepileptic drug use in women of childbearing age. Epilepsy Behav.15(3), 339–343 (2009).
  • Wide K, Winbladh B, Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr.93(2), 174–176 (2004).
  • Matok I, Gorodischer R, Koren G, Landau D, Wiznitzer A, Levy A. Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations. Br. J. Clin. Pharmacol.68(6), 956–962 (2009).
  • Olafsson E, Hallgrimsson JT, Hauser WA, Ludvigsson P, Gudmundsson G. Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia39(8), 887–892 (1998).
  • Holmes LB, Harvey EA, Coull BA et al. The teratogenicity of anticonvulsant drugs. N. Engl. J. Med.344(15), 1132–1138 (2001).
  • Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res.81(1), 1–13 (2008).
  • Artama M, Auvinen A, Raudaskoski T, Isojarvi I, Isojarvi J. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology64(11), 1874–1878 (2005).
  • Holmes LB, Wyszynski DF. North American antiepileptic drug pregnancy registry. Epilepsia45(11), 1465 (2004).
  • Vajda FJ, O’Brien TJ, Hitchcock A, Graham J, Lander C. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months. J. Clin. Neurosci.10(5), 543–549 (2003).
  • Pilo C, Wide K, Winbladh B. Pregnancy, delivery, and neonatal complications after treatment with antiepileptic drugs. Acta Obstet. Gynecol. Scand.85(6), 643–646 (2006).
  • Morrow J, Russell A, Guthrie E et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiatr.77(2), 193–198 (2006).
  • Holmes LB, Baldwin EJ, Smith CR et al. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology70(22 Pt 2), 2152–2158 (2008).
  • Dolk H, Jentink J, Loane M, Morris J, de Jong-van den Berg LT. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology71(10), 714–722 (2008).
  • Cunnington M, Ferber S, Quartey G. Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. Epilepsia48(6), 1207–1210 (2007).
  • Hunt S, Russell A, Smithson WH et al. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology71(4), 272–276 (2008).
  • Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology64(6), 961–965 (2005).
  • Meador KJ, Baker GA, Browning N et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N. Engl. J. Med.360(16), 1597–1605 (2009).
  • Adab N, Kini U, Vinten J et al. The longer term outcome of children born to mothers with epilepsy. J. Neurol. Neurosurg. Psychiatr.75(11), 1575–1583 (2004).
  • Vajda FJ, Hitchcock AA, Graham J, O’Brien TJ, Lander CM, Eadie MJ. The teratogenic risk of antiepileptic drug polytherapy. Epilepsia DOI: 10.1111/j.1528-1167.2009.02336.x (2009) (Epub ahead of print).
  • Almgren M, Källén B, Lavebratt C. Population-based study of antiepileptic drug exposure in utero – influence on head circumference in newborns. Seizure18(10), 672–675 (2009).
  • Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology61(6 Suppl. 2), S35–S42 (2003).
  • Brodtkorb E, Reimers A. Seizure control and pharmacokinetics of antiepileptic drugs in pregnant women with epilepsy. Seizure17(2), 160–165 (2008).
  • Dansky LV, Rosenblatt DS, Andermann E. Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology42(4 Suppl. 5), 32–42 (1992).
  • Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA285(23), 2981–2986 (2001).
  • Pennell PB. Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest? Epilepsia49(Suppl. 9), 43–55 (2008).
  • Morrow JI, Hunt SJ, Russell AJ et al. Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiatr.80(5), 506–511 (2009).
  • Pack AM. Therapy insight: clinical management of pregnant women with epilepsy. Nat. Clin. Pract. Neurol.2(4), 190–200 (2006).
  • Harden CL, Pennell PB, Koppel BS et al. Practice parameter update: management issues for women with epilepsy – focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology73(2), 142–149 (2009).
  • Tauboll E, Gjerstad L, Henriksen T, Husby H. Pregnancy and birth in women with epilepsy. Tidsskr. Nor. Laegeforen.123(12), 1695–1697 (2003).
  • Kjaer D, Horvath-Puho E, Christensen J et al. Antiepileptic drug use, folic acid supplementation, and congenital abnormalities: a population-based case–control study. BJOG115(1), 98–103 (2008).
  • Aguglia U, Barboni G, Battino D et al. Italian consensus conference on epilepsy and pregnancy, labor and puerperium. Epilepsia50(Suppl. 1), 7–23 (2009).
  • Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet358(9298), 2069–2073 (2001).
  • Wilson RD, Johnson JA, Wyatt P et al. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J. Obstet. Gynaecol. Can.29(12), 1003–1026 (2007).
  • Koren G, Goh YI, Klieger C. Folic acid: the right dose. Can. Fam. Physician54(11), 1545–1547 (2008).
  • Kaaja E, Kaaja R, Matila R, Hiilesmaa V. Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology58(4), 549–553 (2002).
  • Artama M, Isojarvi JI, Raitanen J, Auvinen A. Birth rate among patients with epilepsy: a nationwide population-based cohort study in Finland. Am. J. Epidemiol.159(11), 1057–1063 (2004).
  • Pennel PB. Epilepsy. In: Management of High-Risk Pregnancy (5th Edition). Queenan JT, Lockwood CJ (Eds). Blackwell Publishing Ltd, MA, USA, 201–209 (2007).
  • Bjerkedal T, Bahna SL. The course and outcome of pregnancy in women with epilepsy. Acta Obstet. Gynecol. Scand.52(3), 245–248 (1973).
  • Yerby M, Koepsell T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia26(6), 631–635 (1985).
  • Endo S, Hagimoto H, Yamazawa H et al. Statistics on deliveries of mothers with epilepsy at Yokohama City University Hospital. Epilepsia45(Suppl. 8), 42–47 (2004).
  • Katz O, Levy A, Wiznitzer A, Sheiner E. Pregnancy and perinatal outcome in epileptic women: a population-based study. J. Matern. Fetal Neonatal Med.19(1), 21–25 (2006).
  • Viinikainen K, Heinonen S, Eriksson K, Kalviainen R. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia47(1), 186–192 (2006).
  • Kaplan PW, Norwitz ER, Ben-Menachem E et al. Obstetric risks for women with epilepsy during pregnancy. Epilepsy Behav.11(3), 283–291 (2007).
  • Thomas SV, Sindhu K, Ajaykumar B, Sulekha Devi PB, Sujamol J. Maternal and obstetric outcome of women with epilepsy. Seizure18(3), 163–166 (2009).
  • Hvas CL, Henriksen TB, Ostergaard JR. Birth weight in offspring of women with epilepsy. Epidemiol. Rev.22(2), 275–282 (2000).
  • Hiilesmaa VK. Pregnancy and birth in women with epilepsy. Neurology42(4 Suppl. 5), 8–11 (1992).
  • Chen YH, Chiou HY, Lin HC, Lin HL. Affect of seizures during gestation on pregnancy outcomes in women with epilepsy. Arch. Neurol.66(8), 979–984 (2009).
  • Hvas CL, Henriksen TB, Ostergaard JR, Dam M. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. BJOG107(7), 896–902 (2000).
  • Almgren M, Kallen B, Lavebratt C. Population-based study of antiepileptic drug exposure in utero – influence on head circumference in newborns. Seizure18(10), 672–675 (2009).
  • Linton A, Peterson MR. Effect of preexisting chronic disease on primary cesarean delivery rates by race for births in U.S. military hospitals, 1999–2002. Birth31(3), 165–175 (2004).
  • Donaldson JO. Neurological disorders. In: Medical Disorders in Obstetric Practice (4th Edition). Swiet MD (Ed.). Blackwell Science Ltd, London, UK, 486–489 (2002).
  • Harden CL, Hopp J, Ting TY et al. Practice parameter update: management issues for women with epilepsy – focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology73(2), 126–132 (2009).
  • Tauboll E, Gjerstad L, Henriksen T, Husby H. Women and epilepsy. Tidsskr. Nor. Laegeforen.123(12), 1691–1694 (2003).
  • Endo SS, Hagimoto HH, Yamazawa HH et al. Statistics on deliveries of mothers with epilepsy at Yokohama City University Hospital. Epilepsia45(Suppl. 8), 42–47 (2004).
  • Hall MH. Haemorrhage. In: Why Mothers Die 2000–2002: The Sixth Report. Lewis G (Ed.). Royal College of Obstericians and Gynecologists, London, UK, 86–95 (2004).
  • Cunningham FG, MacDonald PC, Gilstrap LC, Gant NF, Hankins GD, Clark SL. Obstetrical hemorrhage. In: Williams Obstetrics (20th Edition). Licht J (Ed.). Appelton & Lange, CT, USA 745–783 (1997).
  • Dean JC, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J. Med. Genet.39(4), 251–259 (2002).
  • Adab N, Tudur SC, Vinten J, Williamson P, Winterbottom J. Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Syst. Rev.3, CD004848 (2004).
  • Thomas SV, Ajaykumar B, Sindhu K, Nair MK, George B, Sarma PS. Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy Behav.13(1), 229–236 (2008).
  • Kantola-Sorsa E, Gaily E, Isoaho M, Korkman M. Neuropsychological outcomes in children of mothers with epilepsy. J. Int. Neuropsychol. Soc.13(4), 642–652 (2007).
  • Titze K, Koch S, Helge H, Lehmkuhl U, Rauh H, Steinhausen HC. Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development. Dev. Med. Child Neurol.50(2), 117–122 (2008).
  • Bromley RL, Mawer G, Clayton-Smith J, Baker GA. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology71(23), 1923–1924 (2008).
  • Nelson-Piercy C. Hypertension and pre-eclampsia. In: Handbook of Obstetric Medicine. Nelson-Piercy C (Ed.). Martin Dunitz Ltd, London, UK, 3–22 (2002).
  • Goh YI, Koren G. Folic acid in pregnancy and fetal outcomes. J. Obstet. Gynaecol.28(1), 3–13 (2008)
  • Battino D, Tomson T. Management of epilepsy during pregnancy. Drugs67(18), 2727–2746 (2007).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.